Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05335993
Title A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors OncoQuest Pharmaceuticals Inc.
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Duke Cancer Center Durham North Carolina 27710 United States Details
Stephenson Cancer Center- University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
University of Virginia Health System Charlottesville Virginia 22903 United States Details
*Shaded cells indicate that there was no data available from for the field